Romainville, France

Amynata Tirera


 

Average Co-Inventor Count = 9.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Amynata Tirera: Innovator in Pharmaceutical Compounds

Introduction

Amynata Tirera is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceutical compounds, particularly in the treatment of inflammatory diseases. With a total of 4 patents to his name, Tirera's work is paving the way for advancements in medical treatments.

Latest Patents

Tirera's latest patents include innovative compounds such as benzamide-substituted bicyclic imidazo- and pyrazolo-fused pyridine, pyrimidine, and pyridazine compounds. These compounds are designed for the treatment of various inflammatory diseases. The inventions disclose methods for producing these compounds, as well as pharmaceutical compositions that can be used for the prophylaxis and treatment of a wide range of diseases, including autoimmune and proliferative diseases, as well as conditions associated with hypersecretion of specific cytokines.

Career Highlights

Throughout his career, Amynata Tirera has worked with prominent companies in the pharmaceutical industry, including Galapagos NV and Onco3R Therapeutics BV. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Tirera has collaborated with notable professionals in his field, including Denis Bucher and Christophe Peixoto. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Amynata Tirera is a distinguished inventor whose work in pharmaceutical compounds is making a significant impact on the treatment of inflammatory diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…